These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 29756397)

  • 1. Topical superoxide dismutase in posttreatment fibrosis in patients with head and neck cancer.
    Landeen KC; Spanos WC; Gromer L
    Head Neck; 2018 Jul; 40(7):1400-1405. PubMed ID: 29756397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventive role of superoxide dismutase on radiation-induced periprosthetic capsule development.
    Can Trabulus D; Altinsoy E; Karacetin D; Nazli MA; Kelten Talu C
    J Surg Res; 2018 Nov; 231():30-35. PubMed ID: 30278944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The basis of topical superoxide dismutase antipruritic activity.
    Diehl C; Lipozencić J; Ledić-Drvar D
    Acta Dermatovenerol Croat; 2009; 17(1):25-39. PubMed ID: 19386213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel topical agent containing superoxide dismutase 100 000 IU and 4% of plant extracts as a mono-therapy for atopic dermatitis.
    Sgouros D; Katoulis A; Rigopoulos D
    J Cosmet Dermatol; 2018 Dec; 17(6):1069-1072. PubMed ID: 29134748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The second phase clinical observation of anti-radiation effect by superoxide dismutase].
    Tu Q; Tang J; Shen L; Lei Y; Yu S; Zhou J; He J; Chen C; Zhang F; Zhang F; Dong F; Peng H; Tan H
    Hunan Yi Ke Da Xue Xue Bao; 1998; 23(3):308-10. PubMed ID: 10681768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of topical misoprostol to reduce radiation-induced mucositis: results of a randomized, double-blind, placebo-controlled trial.
    Veness MJ; Foroudi F; Gebski V; Timms I; Sathiyaseelan Y; Cakir B; Tiver KW
    Australas Radiol; 2006 Oct; 50(5):468-74. PubMed ID: 16981945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Phase III placebo-controlled trial of oral pilocarpine in patients undergoing radiotherapy for head-and-neck cancer.
    Warde P; O'Sullivan B; Aslanidis J; Kroll B; Lockwood G; Waldron J; Payne D; Bayley A; Ringash J; Kim J; Liu FF; Maxymiw W; Sprague S; Cummings BJ
    Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):9-13. PubMed ID: 12182969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II double-blind randomized study comparing oral aloe vera versus placebo to prevent radiation-related mucositis in patients with head-and-neck neoplasms.
    Su CK; Mehta V; Ravikumar L; Shah R; Pinto H; Halpern J; Koong A; Goffinet D; Le QT
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):171-7. PubMed ID: 15337553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantifying fibrosis in head and neck cancer treatment: An overview.
    Moloney EC; Brunner M; Alexander AJ; Clark J
    Head Neck; 2015 Aug; 37(8):1225-31. PubMed ID: 24797251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Head and Neck Radiotherapy Questionnaire: a morbidity/quality-of-life instrument for clinical trials of radiation therapy in locally advanced head and neck cancer.
    Browman GP; Levine MN; Hodson DI; Sathya J; Russell R; Skingley P; Cripps C; Eapen L; Girard A
    J Clin Oncol; 1993 May; 11(5):863-72. PubMed ID: 8487051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of cevimeline to improve oral health in patients with postradiation xerostomia.
    Witsell DL; Stinnett S; Chambers MS
    Head Neck; 2012 Aug; 34(8):1136-42. PubMed ID: 22231734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving the outcome of severe head injury with the oxygen radical scavenger polyethylene glycol-conjugated superoxide dismutase: a phase II trial.
    Muizelaar JP; Marmarou A; Young HF; Choi SC; Wolf A; Schneider RL; Kontos HA
    J Neurosurg; 1993 Mar; 78(3):375-82. PubMed ID: 8433137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Prospective Study of the Lymphedema and Fibrosis Continuum in Patients with Head and Neck Cancer.
    Ridner SH; Dietrich MS; Niermann K; Cmelak A; Mannion K; Murphy B
    Lymphat Res Biol; 2016 Dec; 14(4):198-205. PubMed ID: 27305456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Superoxide dismutase (Cu/Zn) in cutaneous application in the treatment of radiation-induced fibrosis].
    Perdereau B; Campana F; Vilcoq JR; de la Rochefordière A; Barbaroux C; Fourquet A; Magdelenat H
    Bull Cancer; 1994 Aug; 81(8):659-69. PubMed ID: 7703556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical superoxide dismutase reduces post-irradiation breast cancer fibrosis.
    Campana F; Zervoudis S; Perdereau B; Gez E; Fourquet A; Badiu C; Tsakiris G; Koulaloglou S
    J Cell Mol Med; 2004; 8(1):109-16. PubMed ID: 15090266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valid and reliable techniques for measuring fibrosis in patients with head and neck cancer postradiotherapy: A systematic review.
    Shaw SM; Skoretz SA; O'Sullivan B; Hope A; Liu LW; Martino R
    Head Neck; 2016 Apr; 38 Suppl 1():E2322-34. PubMed ID: 26559913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical steroid versus placebo for the prevention of radiation dermatitis in head and neck cancer patients receiving chemoradiotherapy: the study protocol of J-SUPPORT 1602 (TOPICS study), a randomized double-blinded phase 3 trial.
    Zenda S; Yamaguchi T; Yokota T; Miyaji T; Mashiko T; Tanaka M; Yonemura M; Takeno M; Okano T; Kawasaki T; Nakamori Y; Ishii S; Shimada S; Kanamaru M; Uchitomi Y
    BMC Cancer; 2018 Sep; 18(1):873. PubMed ID: 30189840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of concurrent granulocyte macrophage-colony stimulating factor on radiation-induced mucositis in head and neck cancer patients: a double-blind placebo-controlled prospective phase III study by Radiation Therapy Oncology Group 9901.
    Ryu JK; Swann S; LeVeque F; Scarantino CW; Johnson D; Chen A; Fortin A; Pollock J; Kim H; Ang KK
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):643-50. PubMed ID: 17293228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicenter, randomized, double-blind, placebo-controlled, dose-titration study of oral pilocarpine for treatment of radiation-induced xerostomia in head and neck cancer patients.
    LeVeque FG; Montgomery M; Potter D; Zimmer MB; Rieke JW; Steiger BW; Gallagher SC; Muscoplat CC
    J Clin Oncol; 1993 Jun; 11(6):1124-31. PubMed ID: 8501499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicenter Randomized Double-Blind, Placebo-Controlled Trial GORTEC (Groupe Oncologie Radiotherapie Tete et Cou) 2009-01 Evaluating the Effect of the Regenerating Agent on Radiodermatitis of Head and Neck Cancer Patients.
    Tao Y; Auperin A; Sire C; Martin M; Saliou MG; Bardet E; Sun XS; Chatellier T; Morand C; Cornely A; Angokai M; Di Rito A; Kichenin K; Blanchard P; D'Onofrio I; Bourhis J
    Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):590-595. PubMed ID: 29280453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.